Overcoming funding challenges for innovative medtech in Germany: Learnings from the NUB process

April 19, 2021
lab technician with test tubes

Germany is the leading medtech market in Europe, with a 22% market share. While funding for high-cost innovative medtech in Germany has evolved in recent years, there are still many challenges in securing reimbursement even as demand for these technologies surges. In an analysis published in Med Device Online, we explored how medtech companies should approach the reimbursement pathway for these devices when seeking to enter the German market.

Related capabilities

Additional author